IBRD only | Immunization, DPT (% of children ages 12-23 months)
Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
IBRD only
Records
63
Source
IBRD only | Immunization, DPT (% of children ages 12-23 months)
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980 13.78846875
1981 15.058194
1982 17.78954856
1983 37.39192069
1984 44.44645842
1985 49.98058485
1986 52.42860358
1987 57.07232548
1988 68.8582072
1989 72.78209419
1990 80.63875587
1991 76.88840741
1992 75.26456109
1993 75.82348766
1994 77.46671225
1995 77.62937279
1996 77.02821862
1997 76.47974085
1998 76.61870436
1999 76.39305665
2000 76.4922112
2001 77.07492875
2002 76.19857446
2003 77.43599216
2004 78.94038861
2005 79.94442776
2006 81.3150363
2007 81.135393
2008 84.43718647
2009 86.69141418
2010 88.25100089
2011 89.31560092
2012 89.6919223
2013 89.43472084
2014 89.81137508
2015 90.23632152
2016 90.77636968
2017 90.62120282
2018 90.88011348
2019 90.28353783
2020 86.61377693
2021 84.85832848
2022 89.83347193
IBRD only | Immunization, DPT (% of children ages 12-23 months)
Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
IBRD only
Records
63
Source